Showing 17,101–17,120 of 17,987 drug recalls
Drug Recall
Terminated
Historical record Class II
Dexamethasone 10 mg/mL Injectable, 2 mL vial, compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Dexpanthenol 200 mg/mL Injectable, 100 mL vial, compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Betamethasone 6 mg/mL Injectable, 5 mL vial, compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Baclofen/Bupivacaine 2,000 mcg/20 mg/mL Injectable, 45 mL vial, Compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Baclofen 1,000 mcg/mL Injectable, 20 mL and 40 mL vial, Compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Baclofen 500 mcg/mL Injectable, 22 mL vial, Compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Avastin 1.25 mg/0.05 mL Injectable, 4 mL vials, Compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Methotrexate 25mg/mL Injectable, 10 mL vials, Compounded by The Compounding Shop, St. Petersburg, FL by THE COMPOUNDING SHOP, INC.
Reason
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes. Recall initiated
May 2, 2013 Reported by FDA
June 12, 2013 Distribution
Florida, California, Minnesota, and Maine
View recall →
Drug Recall
Terminated
Historical record Class II
Metronidazole Tablets, USP, 500 mg, packaged in a) 10-count tablets per bottle (NDC 54868-0158-3); b) 14-count tablets per bottle (NDC 54868-0158-1); c) 20-count tablets per bottle (NDC 54868-0158-5); d) 21-count tablets per bottle (NDC 54868-0158-0); e) 30-count tablets per bottle (NDC 54868-0158-8), Rx only, Mfg. By: Pliva Krakow Pharma. Comp., Krakow, Poland; Repacked & distributed by: Physicians Total Care, Inc., Tulsa, OK 74146. by Physicians Total Care, Inc.
Reason
Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications. Recall initiated
April 6, 2011 Reported by FDA
June 12, 2013 Distribution
Nationwide
View recall →
Drug Recall
Terminated
Historical record Class II
ZoDen PD, Antihistamine, Nasal Decongestant,16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872 NDC 13811-0073-16 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
ZoDen DM Drops, Antihistamine,Cough Suppressant, Decongestant, , 1 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0080-30 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
Z-Dex Syrup, Decongestant, Antitussive, Expectorant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0002-16 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
Z-Dex Pediatric Drops, Cough Suppressant Decongestant, Expectorant 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0001-30 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
Trigofen DM Drops, Antihistamine,Cough Suppressant, Decongestant, , 1 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0082-30 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
Trigofen Drops, Antihistamine, Decongestant,1 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ, 08872, NDC 13811-0081-30 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
Tri-Dex PE, Antihistamine, Antitussive, Nasal Decongestant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-088-16 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
TL-Hist PD Drops, Antihistamine, Nasal Decongestant,1 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-083-30 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
TL Hist DM, Antihistamine, Decongestant, Cough Suppressant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-068-16 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
TL-DEX DM, Cough Suppressant Decongestant, Expectorant 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-067-16 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Drug Recall
Terminated
Historical record Class II
Mesehist WC, Antihistamine, Antitussive, Decongestant, 16 fl oz. bottle, OTC, Manufactured for: Trigen Laboratories, Sayreville, NJ,08872, NDC 13811-0075-16 by TG United, Inc.
Reason
CGMP Deviations: Products are underdosed or have an incorrect dosage regime. Recall initiated
January 30, 2013 Reported by FDA
June 12, 2013 Distribution
FL, MS, SC, LA and TX
View recall →
Data last updated: October 3, 2026 ET
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer .